Search
for

    Research

    5 / 1000+ results

      research Bernstein’s Consent and Information on Finasteride and Propecia®

      January 2016 in “Hair transplant forum international”
      The document discussed the use of Propecia® (finasteride 1mg), an oral medication by Merck Pharmaceuticals, which blocked the conversion of testosterone to dihydrotestosterone (DHT), a hormone largely responsible for hair loss. It addressed various aspects of finasteride, including its sexual side effects, changes in labeling in 2012, and the condition known as Post-Finasteride Syndrome (PFS). The article also covered topics such as fertility, effects on breast tissue, other adverse reactions, and its relationship with prostate cancer. Additionally, it highlighted the need for caution during pregnancy, considerations for blood donation, the availability of generic finasteride, off-label dosing, and its effects on prostate-specific antigen (PSA) levels and prostate cancer screening.

      research Emerging drugs for hypogonadism

      10 citations , October 2006 in “Expert Opinion on Emerging Drugs”
      New treatments for male hypogonadism are easier to use and target specific tissues to reduce side effects.

      research Mechanisms of testosterone action

      January 2021
      Testosterone works in different ways, including direct interaction with its receptor, conversion to other hormones for specific effects on genitalia, hair, bones, and muscle, and changes in body fat and sexual function when low.

    Community Join

    5 / 1000+ results

    Learn

    5 / 801 results